Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TheraJect
company
About
TheraJect, Inc. is a preclinical stage biopharmaceutical company
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $500K
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2002
- Operating Status
- Active
TheraJect, Inc. is a preclinical stage biopharmaceutical
company committed to the drug delivery including vaccines
via a novel, needle-free transdermal technology.
TheraJect is focused on enhancing the efficacy of existing
vaccines, enabling new vaccines and expanding the global
vaccine market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$500K
TheraJect has raised a total of
$500K
in funding over 2 rounds. Their latest funding was raised on
Aug 6, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 6, 2012 | Grant | $500K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
TheraJect is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
